ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627371; 2) Community: the network communities that were significantly associated with the response to NSC 627371; 3) Molecule: the relationships between components within communities and NSC 627371; 4) MDR: the compounds that were significantly associated with the NSC 627371.

NSC Compound Enrichment Correlation
NSC 668261 Null 0.00138752552318952 0.74770515
NSC 244404 Null 0.00172842815639262 0.39617671
NSC 303861 L-Cysteine analog 0.00172842815639262 0.60940664
NSC 633963 N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride 0.00172842815639262 0.12930466
NSC 651605 Null 0.00172842815639262 0.24323098
NSC 665514 Null 0.00172842815639262 0.53568786
NSC 683694 Null 0.00172842815639262 0.39630134
NSC 687980 Null 0.00172842815639262 0.24578434
NSC 693867 Null 0.00172842815639262 0.4685145
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.00172842815639262 0.53294967
Total:113  Current:8    [First] [Prev] [Next] [Last]